CLINICAL_TRIALS
trial_result
· 2009-10-07
Clinical Trial Update: Tiotropium / Respimat One-Year Study [Phase 3]
Summary
A Phase 3 one-year trial of tiotropium delivered via Respimat for chronic obstructive pulmonary disease has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2009-10-07